Although it has been previously reported that inhibition of EZH2 suppressed GBM growth, migration, and reversed EMT in vitro and in vivo (24, 43–45), this study is the first description demonstrating that EZH2 mediates E2 pro-oncogenic actions on GBM cells. Here, EZH2 is linked to glioblastoma.